Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Obstructive sleep apnea, CPAP therapy, and gastroesophageal reflux symptoms: evidence from a prospective cohort study

View through CrossRef
Background Obstructive sleep apnea (OSA) frequently coexists with gastroesophageal reflux disease (GERD), yet the degree to which hypoxic burden contributes to reflux severity and whether symptoms improve with continuous positive airway pressure (CPAP) remains insufficiently defined. Objective: To investigate the cross-sectional associations of OSA severity and nocturnal hypoxic burden with GERD symptom presence and severity, and to evaluate longitudinal changes in reflux symptoms after CPAP therapy in a prospective follow-up cohort. Methods In a prospective cohort of adults undergoing polysomnography, 580 participants were evaluated at baseline and stratified by GERD status using the GERD-Q (≥8 indicating GERD). OSA severity (apnea–hypopnea index, AHI) and nocturnal hypoxemia burden (T90%, minimum SpO₂, oxygen desaturation index) were compared across reflux strata. Multivariable linear and logistic regression models assessed continuous associations between sleep parameters and GERD severity. A CPAP sub-cohort of moderate-to-severe OSA with concomitant reflux ( n  = 150; completed follow-up, n  = 112) was monitored for GERD-Q changes at 3 and 6 months. Results GERD prevalence reached 29.0%. GERD-Q scores demonstrated dose–response escalation across both OSA severity and hypoxemia categories ( p for trend <0.001). T90% and ODI showed stronger associations with reflux burden than AHI in fully adjusted models (T90% β  = 0.81; ODI β  = 0.44; both p  < 0.001), while minimum SpO₂ remained inversely related ( β  = −0.18; p  = 0.003). Logistic models confirmed increased GERD risk in moderate (OR = 1.87) and severe OSA (OR = 2.74), and in patients with marked nocturnal hypoxemia (T90 > 10%; OR = 3.42; all p  < 0.001). CPAP therapy yielded progressive symptom reduction (GERD-Q − 1.92 at 3 months; −3.28 at 6 months), with clinically meaningful improvement in 69.6% at 6 months. Conclusion OSA severity and nocturnal desaturation jointly predict reflux symptom burden, with hypoxic load outperforming event frequency. CPAP produced sustained GERD symptom improvement over 6 months.
Title: Obstructive sleep apnea, CPAP therapy, and gastroesophageal reflux symptoms: evidence from a prospective cohort study
Description:
Background Obstructive sleep apnea (OSA) frequently coexists with gastroesophageal reflux disease (GERD), yet the degree to which hypoxic burden contributes to reflux severity and whether symptoms improve with continuous positive airway pressure (CPAP) remains insufficiently defined.
Objective: To investigate the cross-sectional associations of OSA severity and nocturnal hypoxic burden with GERD symptom presence and severity, and to evaluate longitudinal changes in reflux symptoms after CPAP therapy in a prospective follow-up cohort.
Methods In a prospective cohort of adults undergoing polysomnography, 580 participants were evaluated at baseline and stratified by GERD status using the GERD-Q (≥8 indicating GERD).
OSA severity (apnea–hypopnea index, AHI) and nocturnal hypoxemia burden (T90%, minimum SpO₂, oxygen desaturation index) were compared across reflux strata.
Multivariable linear and logistic regression models assessed continuous associations between sleep parameters and GERD severity.
A CPAP sub-cohort of moderate-to-severe OSA with concomitant reflux ( n  = 150; completed follow-up, n  = 112) was monitored for GERD-Q changes at 3 and 6 months.
Results GERD prevalence reached 29.
0%.
GERD-Q scores demonstrated dose–response escalation across both OSA severity and hypoxemia categories ( p for trend <0.
001).
T90% and ODI showed stronger associations with reflux burden than AHI in fully adjusted models (T90% β  = 0.
81; ODI β  = 0.
44; both p  < 0.
001), while minimum SpO₂ remained inversely related ( β  = −0.
18; p  = 0.
003).
Logistic models confirmed increased GERD risk in moderate (OR = 1.
87) and severe OSA (OR = 2.
74), and in patients with marked nocturnal hypoxemia (T90 > 10%; OR = 3.
42; all p  < 0.
001).
CPAP therapy yielded progressive symptom reduction (GERD-Q − 1.
92 at 3 months; −3.
28 at 6 months), with clinically meaningful improvement in 69.
6% at 6 months.
Conclusion OSA severity and nocturnal desaturation jointly predict reflux symptom burden, with hypoxic load outperforming event frequency.
CPAP produced sustained GERD symptom improvement over 6 months.

Related Results

0864 Severe Central Sleep Apnea
0864 Severe Central Sleep Apnea
Abstract Introduction Central sleep apnea (CSA) is a rare form of sleep disordered breathing with repeated apneic episodes with ...
0696 The O2VERLAP Study: High Cpap Use Levels Found In Overlap Syndrome (OSA And COPD) Patients
0696 The O2VERLAP Study: High Cpap Use Levels Found In Overlap Syndrome (OSA And COPD) Patients
Abstract Introduction CPAP therapy is prescribed to help manage disordered breathing during sleep time periods. Most users, espe...
High prevalence of obstructive sleep apnea in Marfan's syndrome
High prevalence of obstructive sleep apnea in Marfan's syndrome
Objective To review the current evidence about the prevalence of obstructive sleep apnea in patients with Marfan's syndrome, and discuss some proposed potential mechani...
0683 CPAP Adherence Relative To Sleep Duration And Sleep Period In Different Study Populations
0683 CPAP Adherence Relative To Sleep Duration And Sleep Period In Different Study Populations
Abstract Introduction CPAP is intended for use during sleep to alleviate disordered breathing. Most patients who use CPAP do so ...
0582 Exploring a Supplemental Measure of CPAP Adherence
0582 Exploring a Supplemental Measure of CPAP Adherence
Abstract Introduction Obstructive sleep apnea (OSA) is highly prevalent in the Veteran population. The prevailing treatment for ...
Mood Predicts Response to Placebo CPAP
Mood Predicts Response to Placebo CPAP
Study Objectives. Continuous positive airway pressure (CPAP) therapy is efficacious for treating obstructive sleep apnea (OSA), but recent studies with placebo CPAP (CPAP administe...
0539 Predictors of Driving Risk in CPAP-treated OSAS: A French Multicenter Prospective Cohort
0539 Predictors of Driving Risk in CPAP-treated OSAS: A French Multicenter Prospective Cohort
Abstract Introduction Continuous Positive Airway Pressure (CPAP) therapy is effective in reducing Excessive Daytime Sleepiness (...
Gel pillow designed specifically for obstructive sleep apnea treatment with continuous positive airway pressure
Gel pillow designed specifically for obstructive sleep apnea treatment with continuous positive airway pressure
ABSTRACT Objective: To determine whether the use of a gel pillow with side cutouts designed to accommodate a continuous positive airway pressure (CPAP) mask and reduce head tempera...

Back to Top